Document:

Unassociated Document

     

    Exhibit 10.1

    
 

    Frezer,
      Inc.

    936A
      Beachland Boulevard, Suite 13

    Vero
      Beach, Florida 32963

    

    

    Strictly
      Private and Confidential

    

    November
      7, 2007

    

    Mr.
      Peter
      B. Williamson

    Chairman
      of the Board

    Breakthrough
      Venture Corp.

    122
      Sherbourne Street

    Toronto,
      Ontario M5A 2R4

    Canada

    

    Re:
      Letter of Intent

    

    Dear
      Mr.
      Williamson:

    

    Further
      to our recent discussions, this letter of intent (“LOI”) summarizes the terms
      upon which Frezer, Inc. (“FRZR”) intends to combine with Breakthrough Venture
      Corp. (“Breakthrough”) either through a merger between Breakthrough and a wholly
      owned subsidiary of FRZR, or an exchange of shares of stock of Breakthrough
      for
      shares of common stock, par value $0.001 per share (“Common Stock”) of FRZR (the
“Merger”). The parties intend to begin preparation of agreements necessary for
      the Merger (“Definitive Agreements”) in accordance with the following
      terms:

    

    
      	 	
              1.

            	
              Merger.
                At
                closing of the Merger (“Closing”), FRZR will issue restricted shares of
                its convertible preferred stock to the existing stockholders of
                Breakthrough (“Existing Holders”). The preferred shares will be
                convertible into shares of FRZR’s common stock (“Conversion Shares”) and
                shall have the right to vote along with the common stock, on an
                as-converted basis, on all matters on which the common stock is entitled
                to vote. The Conversion Shares issued to the Existing Holders, in
                the
                aggregate, together with any outstanding options, warrants and other
                convertible securities (“Securities”) of Breakthrough that are assumed by
                FRZR in connection with the Merger, along with any securities issued
                to
                investors in the private placement offering (“Offering”), will represent
                96% of the issued and outstanding shares of common stock of FRZR
                on a
                fully diluted and as-converted basis following the Merger. The parties
                acknowledge that the structure will be designed to satisfy Breakthrough’s
                desire to remain a Canadian controlled company for tax
                purposes.

            

    

    

    The
      Merger Agreement will contain warranties, representations, covenants and
      conditions as are customary for transactions of this nature, including
      indemnification from AAAA for six months following closing to the extent of
      the
      reverse merger fee, subject to a “basket” as to which no claim can be made until
      all such claims for indemnification exceed $75,000.

    

    
      	 	
              2.

            	
              Private
                Placement. A
                condition to Closing will be the completion of a private placement
                of
                securities raising gross proceeds of at least $14 million on terms
                substantially in accordance with the terms described in the attached
                Schedule A (the “Offering”). Breakthrough will engage BBBB as its
                exclusive placement agent for the Offering in the manner described
                on
                Schedule A. The parties desire the Offering to be completed no later
                than
                March 15, 2008.

            

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    

    
      	 	
              3.

            	
              Consultant.
                At
                Closing, David J. Levenson will be issued a number of shares of restricted
                common stock of FRZR equal to 0.4% of the fully-diluted common stock
                of
                FRZR post-Closing.  For purposes of clarity, the shareholders of
                Breakthrough immediately prior to the Closing, along with new investors
                in
                the Offering, will hold 96% of the fully-diluted common stock of
                FRZR
                post-Closing, the stockholders of FRZR immediately prior to the Closing
                will hold 3.6% of the fully-diluted common stock of FRZR post-Closing,
                and
                David J. Levenson will hold 0.4% of the fully-diluted common stock
                of FRZR
                post-Closing.

            

    

    

    In
      addition, Mr. Levenson will receive a $37,500 consulting fee from
      CCCC.

    

    
      	 	
              4.

            	
              Audit.
                A
                condition to Closing will be that Breakthrough shall have
                delivered the balance sheet as of the end of the last fiscal year
                and the
                related statements of operations, shareholders' equity and cash flows
                for
                the last two fiscal years ended October 31, 2007, audited by an accounting
                firm which is registered with the U.S. Public Company Accounting
                Oversight
                Board (“PCAOB”) (“Accountant"), and the reviewed interim financial
                statements for the three months ended January 31, 2008, with all
                such
                statements having been prepared in accordance with U.S. generally
                accepted
                accounting principles, SEC rules and regulations, (collectively,
                the
                “Financial Statements”);

            

    

     

    
      	 	
              5.

            	
              Registration.
                DDDD,
                Kevin R. Keating and Garisch Financial, Inc. (collectively, the “Current
                FRZR Holders”) will receive piggyback registration rights with respect to
                all FRZR common stock owned by them as a condition to the Merger.
                Even if
                registered, the shares held DDDD would be subject to a lock-up permitting
                sale starting six months after the effectiveness of the registration
                statement with respect to shares underlying securities issued in
                the
                Financing 

            

    

    

    
      	 	
              6.

            	
              Additional
                Conditions. All
                necessary consents of third parties will be obtained prior to Closing.
                Definitive Agreements will contain customary representations, warranties
                and covenants. The board of directors of FRZR and the board of directors
                and shareholders of Breakthrough shall have approved the Definitive
                Agreements. The parties desire Closing to be completed no later than
                March
                15, 2008.

            

    

    

    
      	 	
              7.

            	
              Additional
                Agreements.

            

    

    

    
      	 	
              a.

            	
              Board
                Seat. Breakthrough
                agrees to use its best efforts to include on its Board for a period
                of one
                (1) year following the Closing a person designated by DDDD, which
                designee
                shall be subject to the reasonable consent of the management of
                Breakthrough. At Closing, Breakthrough will deliver voting agreements
                on
                behalf of current Breakthrough shareholders who will represent more
                than
                50% of the outstanding voting stock of FRZR following the Merger
                agreeing
                to vote for person designated by
                DDDD.

            

    

    

    
      	 	
              b.

            	
              After
                Market Support. Breakthrough
                agrees to engage EEEE, a wholly-owned subsidiary of CCCC, to provide
                a
                comprehensive investor relations and after market support program
                (including development and execution of a plan for a NASDAQ listing)
                for a
                term of twelve (12) months following the Closing, or until such time
                as
                Breakthrough becomes listed on NASDAQ. Professional fees for these
                services are $10,000 per month payable quarterly in advance during
                the
                term. EEEE professional fees and $240,000 for third-party expenses
                in
                connection with after market support campaigns will be escrowed at
                Closing
                of the Merger and the Offering. All third-party expenses will be
                subject
                to approval in advance by
                Breakthrough.

            

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    

    

    
      	 	
              8.

            	
              No-Shop.
                In consideration of the expense and effort that will be expended
                by FRZR
                and Breakthrough in due diligence and the negotiation of the Definitive
                Agreements, neither Breakthrough nor its affiliates will, directly
                or
                indirectly, solicit or entertain offers from, negotiate with or in
                any
                manner encourage, discuss, accept or consider any proposal of any
                other
                person or entity relating to a transaction of the type set forth
                herein or
                any other potential merger, acquisition, sale or financing transaction
                (other than the Offering to take place prior to the Closing) until
                the
                earlier to occur of: (i) March 31, 2008, if and only if the Offering
                has
                not been completed prior to March 31, 2008, (ii) the Closing, or
                (iii) the
                date on which FRZR and Breakthrough mutually agree in writing to
                discontinue negotiations. Neither FRZR,
                AAAA,
                nor DDDD, nor any of their officers, directors,
                employees,
                stockholders, advisors, representatives or affiliates will enter
                into or
                continue any negotiations or discussions with other parties relating
                to a
                reverse acquisition or reverse merger transaction involving FRZR
                until the
                earlier to occur of: (i) March 31, 2008, if and only if the Offering
                has
                not been completed prior to March 31, 2008, (ii) the Closing, or
                (iii) the
                date on which FRZR and Breakthrough mutually agree in writing to
                discontinue negotiations.

            

    

    

    
      	 	
              9.

            	
              Definitive
                Agreements;
                Consents.
                FRZR and Breakthrough shall negotiate in good faith to arrive at
                mutually
                acceptable Definitive Agreements for approval, execution and delivery
                on
                the earliest practicable date. The parties shall cooperate with each
                other
                and proceed, as promptly as is reasonably practicable, to seek to
                obtain
                all necessary consents and approvals, if any, from third parties
                or
                governmental entities, and to endeavor to comply with all other legal
                or
                contractual requirements for, or preconditions to, the execution
                and
                consummation of the Definitive
                Agreements.

            

    

    

    
      	 	
              10.

            	
              Confidentiality.
                The parties each covenant and agree that, except as consented to
                by the
                parties, neither they nor any of their respective officers, directors,
                employees, agents or representatives will disclose any confidential
                information of the other to any third party, except (i) as required
                by law
                or regulation (including applicable securities regulations) or (ii)
                to a
                party’s accountants, lawyers, employees, advisors and representatives in
                connection with evaluating whether to proceed with negotiating and
                closing
                the transactions contemplated herein or (iii) in connection with
                obtaining
                consents required by the Definitive Agreements. All confidential
                information will be returned to the other party if the Merger or
                Offering
                are not completed. Neither party will make any public comment, statement
                or communication with respect to, or otherwise disclose or permit
                the
                disclosure of the existence of discussions regarding, a possible
                transaction among the parties or any of the terms, conditions or
                other
                aspects of the transactions described herein. Notwithstanding the
                foregoing, the parties acknowledge that FRZR will prepare and file
                a
                Current Report on Form 8-K to report the execution of this
                LOI.

            

    

    

    
      	 	
              11.

            	
              Costs.
                Each party shall be responsible for and bear all of their own costs
                and
                expenses incurred in connection with the proposed transaction.
                Breakthrough will pay CCCC an advisory fee of $500,000 for advisory
                services rendered to FRZR in connection with the Merger (“Advisory Fee”).
                A non-refundable due diligence fee of $25,000 is payable upon signing
                this
                LOI. The balance of $475,000 shall be payable at the Closing of the
                Merger. In addition, Breakthrough shall be responsible for completing
                a
                Kroll background check on Breakthrough and its two principal
                officers.

            

    

    

    
      	 	
              12.

            	
              No
                Material Changes in Business.
                From and after the date of this LOI until the earliest to occur of
                the
                termination of this LOI, March 31, 2008, or the date of execution
                of the
                Definitive Agreements, the parties will use commercially reasonable
                efforts to maintain their respective businesses in accordance with
                customary practices and otherwise to conduct their respective businesses
                in the ordinary course in the manner in which it has heretofore been
                conducted and to preserve their business relationships with customers,
                suppliers and content providers. During such time, Breakthrough shall
                notify FRZR of any action outside the ordinary course of business
                or any
                commitment involving more than $20,000. FRZR shall notify Breakthrough
                of
                any action outside the ordinary course of business or any commitment
                involving more than $20,000.

            

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    

    
      	 	
              13.

            	
              Binding
                Nature of Letter.
                Sections 1-6 of this LOI (the “Non-Binding Provisions”) reflect our mutual
                understanding of the matters described in them, but each party
                acknowledges that the Nonbinding Provisions are not intended to create
                or
                constitute any legally binding obligation between the parties. No
                party to
                this LOI shall have any liability to any other party based upon,
                arising
                from, or relating to the Non-Binding Provisions. Sections 7-12 of
                this LOI
                (the “Binding Provisions”) shall constitute the legally binding and
                enforceable agreement of the parties (in recognition of the significant
                costs to be borne by the parties in pursuing the transactions set
                forth
                herein). The Binding Provisions (along with the rest of this LOI)
                may be
                terminated (i) by mutual written consent of both parties; or (ii)
                upon
                written notice by either party to the other if the Definitive Agreements
                have not been executed by December 31, 2007, provided, however, that
                the
                termination of the Binding Provisions shall not affect the liability
                for
                breach of any of the Binding Provisions prior to the
                termination.

            

    

    

    
      	 	
              14.

            	
              Counterparts,
                etc.
                This LOI may be executed in separate counterparts, none of which
                need to
                contain all the signatures of all parties, each of which shall be
                deemed
                to be an original, and all of which taken together constitute one
                and the
                same instrument. The Binding Provisions may only be amended in writing
                signed by both parties. The Binding Provisions reflect the entire
                agreement among the parties with respect to the subject matter thereof.
                This LOI may not be assigned. Telecopied or email (via PDF) signatures
                shall be deemed to have the same effect as an original. This LOI
                shall be
                governed by the internal laws of the State of Colorado. Any dispute
                arising hereunder shall be resolved through binding arbitration to
                be held
                in Denver, Colorado in accordance with the international rules of
                the
                American Arbitration Association.

            

    

    

    [Remainder
      of this page left blank.]

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    If
      you
      are in agreement with the foregoing as a basis for negotiating Definitive
      Agreements between us with respect to the matters set forth herein, please
      return a signed copy of this LOI to the undersigned no later than November
      7,
      2007, after which time this LOI will expire if not so accepted.

     

    
      	 	
              Sincerely,

            
	 	 	 
	 	
              Frezer,
                Inc.

            
	 	 	 
	 	 	 
	 	
              By:
                

            	
              /s/
                Kevin R. Keating

            
	 	 	
              Kevin
                R. Keating, President

            

    

    

    
      	
              ACCEPTED
                AND AGREED:

            	 
	 	 	 
	
              Breakthrough
                Venture Corp.

            	 
	 	 	 
	 	 	 
	
              By:
                

            	
               
                /s/ Peter B. Williamson

            	 
	 	
              Peter
                B. Williamson, Chairman of the Board

            	 

    

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    SCHEDULE
      A

    

    TERMS
      OF OFFERING

    

    
      	 	
              Issuer:

            	
              Frezer,
                Inc. (“Frezer).

            

    

    

    
      	 	
              Exclusive
                Placement Agent:

            	
              BBBB,
                operating on a “best efforts” basis, Placement Agent Agreement (“Placement
                Agreement”) to be entered into on or before November 23, 2007, with Frezer
                and Breakthrough Venture Corp.
                (“Breakthrough”).

            

    

    

    
      	 	
              Amount
                to be Raised:

            	
              $14
                million.

            

    

    

    
      	 	
              Securities
                to be Issued:

            	
              Investment
                units (the “Units”) of common stock and warrants (or preferred stock
                equivalents automatically convertible into common stock and warrants).
                Investors will receive 50% warrant coverage at an exercise price
                of 125%
                of the unit offering price. See Schedule B for a post-offering and
                reverse
                merger capitalization table on a fully-diluted
                basis.

            

    

    

    
      	 	
              Pre-Money
                Valuation:

            	
              $37
                million.

            

    

    

    
      	 	
              Warrants:

            	
              The
                Warrants will be exercisable, in whole or in part, at an exercise
                price
                equal to 125% of the offering price. The Warrants may be exercised
                at any
                time beginning on the date of issuance and ending on the fifth anniversary
                of the final closing of the
                Offering.

            

    

    
      	 	 	 

    

    
      	 	
              Forced
                Exercise:

            	
              Breakthrough
                will have the right to require the Warrant holder to exercise the
                Warrant
                if the common stock is quoted on the NASDAQ Capital market and, for
                a
                period of 20 consecutive trading days, the closing bid price of the
                common
                stock has been above $1.50 per share and the daily trading volume
                has been
                at least 200,000 shares, in each case on each of the 20 consecutive
                trading days.

            

    

    

    
      	 	
              Offering
                Materials:

            	
              Private
                Placement Memorandum including all “Form 10 Information” as defined by SEC
                rules.

            

    

    

    
      	 	
              Compensation:

            	
              The
                Placement Agent shall receive (i) 7% of the gross proceeds raised
                in the
                Offering, (ii) a non-accountable expense allowance (“Allowance”) of 2% of
                the gross proceeds raised in the Offering, including a $25,000
                non-refundable advance against the Allowance upon signing the Placement
                Agreement, and (iii) five-year cashless, non-redeemable warrants
                to
                purchase 10% of the number of shares of common stock sold in the
                Offering
                (excluding any common stock underlying the warrants included as part
                of
                the Offering) at an exercise price equal to 125% of the offering
                price,
                sold for a nominal price (“Agent
                Warrants”).

            

    

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    

    
      	 	
              Registration:

            	
              Frezer
                will, and Breakthrough will cause Frezer, to register for resale
                on a
                registration statement (“Registration Statement”) to be filed with the SEC
                within thirty days following the Closing (the “Filing Deadline”): (i) the
                shares of its common stock sold in the Offering (“Common Stock”), and (ii)
                the shares of its common stock underlying the warrants issued in
                the
                Offering (“Equity Warrants”). The Registration Statement will be declared
                effective by the SEC within 120 days after the Closing (the “Effectiveness
                Deadline”). In the event the Registration Statement is not filed or
                declared effective in a timely manner, Breakthrough and Frezer will
                be
                required to pay customary penalties to investors in the Offering
                as
                described below. The Effectiveness Deadline can be extended for up
                to an
                additional 60 days solely as a result of responding to comments from
                the
                Securities and Exchange Commission relating to SEC Rule
                415.

            

    

    

    
      	 	
              Registration
                Penalties:

            	
              If
                the Registration Statement is not filed by the Filing Deadline or
                does not
                become effective by the Effectiveness Deadline, Breakthrough will
                be
                required to pay Investors in cash an amount equal to 1% of the purchase
                price of each Unit held by Investors on such Filing Deadline,
                Effectiveness Deadline, as applicable, and for every 30 day period
                (or
                part) thereafter, in each case until cured (“Registration Delay
                Payments”), provided that the Registration Delay Payments shall not exceed
                10% of the purchase price of the Offering. In the event that the
                Registration Delay Payments are not made in a timely manner, such
                Registration Delay Payments shall bear interest at a rate of 1.5%
                per
                month (or the highest amount permitted by law, if lower) until paid
                in
                full.

            

    

    

    
      
         

      

      
        7EMPLOYMENT
      AGREEMENT

     

    THIS
      AGREEMENT ("Agreement") is made and entered into effective the 6th day of
      November, 2007 by and among BIOANALYTICAL SYSTEMS, INC. (“BASi”, “Company”) a
      corporation organized under the laws of the State of Indiana, and Michael R.
      Cox, ("Employee") as Vice President-Chief Financial Officer and Chief
      Administrative Officer of BASi. This agreement replaces and supersedes the
      employment agreement between BASi and Employee dated April 1, 2004.

     

    Preliminary
      Statements:

     

    A.        BASi
      is engaged in the business of providing contract research services and
      manufacturing and distributing scientific instruments. The Company is in the
      business of conducting laboratory experiments and research on behalf of other
      businesses (“Business”) which is expected to add significantly to the value of
      the Company and BASi.

     

    B.        Employee
      is experienced in the Business, and is familiar with the management and
      operations of the Company. The Company wishes to continue to employ Employee
      on
      the terms and conditions contained herein. 

     

    In
      consideration of the premises and mutual covenants and agreements contained
      herein, the parties hereby agree as follows:

     

    ARTICLE
      1

     

    Term,
      Compensation, and Benefits

     

    Section
      1.1.
      Term
      The
      Company hereby agrees to employ the Employee, and the Employee hereby accepts
      employment with the Company, on the terms and conditions set forth in this
      Agreement until December 30, 2010 (the “Initial Term”). The Initial Term shall
      be extended for successive one year periods (the “Additional Terms,” and
      together with Initial Term, the “Employment Period”)), except that if either
      Employee or Company gives the other party written notice at least ninety days
      (90) before the end of the Initial Term, then this Agreement shall expire at
      the
      end of its then current term. The Employee shall take absences at such time
      as
      shall be approved by the Chief Executive Officer.

     

    Section
      1.2 Compensation
      and Benefits

     

    Section
      1.2.1 Salary:
      BASi
      will pay an initial base salary of $13,750.00 per month. Salary shall be paid
      in
      equal semi-monthly installments in arrears. All amounts to be paid hereunder
      shall be paid in accordance with normal payroll procedures of the Company and
      shall be subject to all required withholdings and deductions.

     

    Section
      1.2.2. Stock Options:
      Employee
      has been granted options to purchase BASi shares. Such options will continue
      under their initial terms and conditions. Company may also grant additional
      options to employee at the discretion of its Board of Directions, with terms
      and
      conditions determined at the time of grant. 

     

    Section
      1.2.3.
      Bonus:
      Employee will also be eligible for bonus grants under bonus plans adopted by
      the
      Company at the discretion of the Compensation Committee of the Board of
      Directors. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Section
      1.2.4 Vacation
      Policy: During
      the initial term, Employee will accumulate one (1) vacation day per month in
      accordance with policies described in the BASi Employee Handbook. Employee
      shall
      also be granted an additional ten days vacation at the start of the initial
      term, and again at the start of any subsequent term, effectively granting
      employee 15 years seniority. Employee's compensation shall continue to be paid
      in full during this period. Any vacation at the end of any year ending on an
      anniversary date shall carry over to the following one-year period commencing
      on
      such anniversary date (the “Following Year”), but shall not carry over beyond
      the Following Year. Vacation time not used prior to the expiration will be
      banked for short-term disability as described in the BASi Employee Handbook.
      

     

    Section
      1.2.5 Other
      Benefits:
      During
      the Employment Period, the Employee shall be entitled to participate in all
      employee benefit plans which are generally made available to employees of the
      Company, subject to the eligibility, qualification, waiting period and other
      terms and conditions of such plans as they shall be in effect from time to
      time
      unless listed herein as exceptions from those terms and conditions. The
      highlights of the benefits are as follows: group health insurance (after ninety
      days); two weeks unpaid vacation (optional); term life insurance ($100,000);
      long term disability insurance; and a 401K deferred tax savings incentive/profit
      sharing plan. Optional participation benefits include a flexible spending
      account, dental, vision, and short-term disability. 

     

    ARTICLE
      2

     

    Duties

     

    Section
      2.1. Duties 

    

    During
      the Employment Period, the Employee will be the ranking financial and
      administrative officer of the company. The Employee will lead the accounting,
      treasury, human resources, facilities and administrative areas of the Company.
      The employee will be called upon to perform certain services for the Company,
      including, without limitation, the following

    

    a)
      Recruit, train, monitor and manage corporate accounting staff at all sites
      in
      appropriate current practices
      and regulatory requirements.

    b)
      Ensure
      sufficient internal controls over financial transactions and reporting to meet
      internal operating
      and public reporting requirements.

    c)
      Provide senior management and direction to the Company’s Information
      Technology
      department.

    d)
      Serve
      as the principal compliance officer for the Company’s responsibilities with the
      Securities and
      Exchange Commission.

    e)
      Manage
      the Company’s human resources, administrative and facilities
      operations.

    f)
       Select and maintain relationships with the Company’s banks. 

    g)
      Determine the amount, timing and required sources for financing the capital
      and
      operational financial
      needs.

    h)
      Set
      financial goals and measure attainment for the operational units with the
      Company.

    i) 
      Collaborate with the Company’s other executive officers in planning and managing
      the affairs of
      the
      Company. 

     

    Section
      2.2 The
      employee shall serve the Company by performing such other services as
      the

    Company
      may reasonably require to conduct the Company’s business. The Company shall also
      have the absolute right and power to direct and control the Employee in carrying
      out duties assigned by the Company, including, but not limited to, the right
      (1)
      to review, modify and cancel all work performed, and (2) to assign specific
      duties to be performed, including the general means and manner by which such
      duties shall be performed. Notwithstanding any other provisions of this
      Agreement, the Company shall not impose employment duties or constraints of
      any
      kind upon the Employee which would require the Employee to violate any
      ordinance, regulation, statute or other law. The Employee shall devote his
      full
      working time, attention and energy to the performances of the duties imposed
      hereunder. The Employee shall conform to such hours of work as may from time
      to
      time reasonably be required of him and shall not be entitled to receive any
      additional remuneration for work outside his normal hours. The Employee will
      NOT
      be held
      financially, legally, or otherwise liable for any past practices or actions
      or
      decisions made by BASi, or its predecessors prior to the start of the Employee’s
      beginning date of employment.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    ARTICLE
      3

     

    Confidentiality
      and Other Matters

     

    Section
      3.1.
      Confidentiality
      Agreement.
      The
      Employee, prior to and during the term of employment under this Agreement,
      has
      had and will have access to and has become or will become familiar with
      information, whether or not originated by the Employee, which is used in or
      related to the Business or the business of BASi or certain subsidiaries or
      affiliates of BASi and is (a) proprietary to, about, or created by the Company
      its subsidiaries or its affiliates; (b) designated as confidential by the
      Company, its subsidiaries or its affiliates; or (c) not generally known to
      or
      ascertainable by proper means by the public ("Confidential
      Information").

     

    Further,
      the Employee has had and will have access to items proprietary to the Company,
      its subsidiaries or its affiliates ("Proprietary Items"). "Proprietary Items"
      shall mean all legally-recognized rights which result from or are derived from
      the Employee's work product or the work product of others made for the Company,
      its subsidiaries or its affiliates, including all past, present and future
      work
      product made for the Company, its subsidiaries or its affiliates, or with
      knowledge, use or incorporation of Confidential Information, including, but
      not
      limited to works of authorship, developments, inventions, innovations, designs,
      discoveries, improvements, trade secrets, trademarks, applications, techniques,
      know-how and ideas, whether or not patentable or copyrightable, conceived or
      made or developed by the Employee (solely or in cooperation with others) or
      others during the term of this Agreement or prior to or during his tenure with
      the Company, or which are reasonably related to the Business or the business
      of
      BASi or certain subsidiaries or affiliates of BASi or the actual or demonstrably
      anticipated research and development of the Company.

     

    The
      Employee agrees that any Confidential Information and Proprietary Items will
      be
      treated in full confidence and shall not be used, directly or indirectly, by
      him, nor shall the same be disclosed to any other firms, organizations, or
      persons outside of the Company's employees bound by similar agreement, during
      the term of this Agreement or at any time thereafter, except as required in
      the
      course of his employment with the Company. All Confidential Information and
      Proprietary Items, whether prepared by the Employee or otherwise, coming into
      his possession, shall remain the exclusive property of the Company and shall
      not
      be permanently removed from the premises of the Company under any circumstances
      whatsoever, without the prior written consent of the Company.

     

    The
      Employee will not be obliged to keep information confidential to the extent
      that
      the information has ceased to be confidential and has entered the public domain
      otherwise than due to the Employee's acts. The provisions of this Section
      3.1
      shall be
      in addition to, and shall not affect, the Employee's common law duty of fidelity
      to the Company.

     

    Section
      3.2.
      The
      parties foresee that the Employee may make inventions or create other
      intellectual property in the course of his duties hereunder and agree that
      in
      this respect the Employee has a special responsibility to further the interests
      of the Company and its affiliates.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Section
      3.3
      The
      Employee agrees that during the Employee’s employment with the Company and for
      an additional period of the two (2) years immediately following termination
      of
      the Employee’s employment with the Company, the Employee shall not directly or
      indirectly, as an individual or as a director, officer, contractor, employee,
      consultant, partner, investor or in any other capacity with any corporation,
      partnership or other person or entity, other than the Company (an “Other
      Entity”), (i) contact or communicate any then current material customer or
      client of the Company in the Business, or any person or entity with which the
      Company is then engaged in material discussions regarding that person or entity
      becoming a client or customer of the Company in the Business, for the purpose
      of
      inducing any such customer or client to move its account from the Company to
      another company in the Business; provided, however, that nothing in this
      sentence shall prevent the Employee from becoming employed by or providing
      consulting services to any such customer or client of the Company in the
      Business, or (ii) solicit any other employee of the Company for employment
      or a
      consulting or other services arrangement with an Other Entity. The restrictions
      of this Section
      3.3
      shall
      not be deemed to prevent the Employee from owning not more than 5% of the issued
      and outstanding shares of any class of securities of an issuer whose securities
      are listed on a national securities exchange or registered pursuant to Section
      12(g) of the Securities Exchange Act of 1934, as amended. In the event a court
      of competent jurisdiction determines that the foregoing restriction is
      unreasonable in terms of geographic scope or otherwise then the court is hereby
      authorized to reduce the scope of said restriction and enforce this Section
      3.3
      as so
      reduced. If any sentence, word or provision of this Section
      3.3
      shall be
      determined to be unenforceable, the same shall be severed herefrom and the
      remainder shall be enforced as if the unenforceable sentence, word or provision
      did not exist. Notwithstanding any provision of this Agreement to the contrary,
      the terms and conditions of this Section
      3.3
      shall
      survive for a period of two (2) years following termination of the Employee’s
      employment with the Company, at which time the terms and conditions of this
      Section
      3.3
      shall
      terminate.

     

    Section
      3.4 The
      Employee agrees to abide by all the conditions of the Company Code of Conduct
      and
      Ethics. 

    

    Section
      3.5 As
      CFO,
      the Employee agrees to adopt and fulfill all the obligations dictated in the
      Company
      Disclosure Committee Charter as a Certifying Officer of Bioanalytical Systems,
      Inc. 

     

    ARTICLE
      4 

     

    Termination
      of Employment

     

    Section
      4.1.
      Resignation
      by the Employee.
      The
      Employee may resign from his employment with the Company at any time by
      providing written notice to the Company of resignation at least ninety days
      (90)
      prior to the effective date of the resignation (the "Resignation Date”).
      Employee may resign at any time for “good reason,” due to (a) a material breach
      of this Agreement by the Company which continues after the Employee has given
      the Company thirty days (30) written notice of such breach, or (b) the
      assignment to the Employee of duties materially inconsistent with this Agreement
      other than in accordance with the terms of this Agreement, and the Company
      has
      not rectified such assignment within thirty days (30) after the Employee has
      given the Company written notice of such breach. A termination by the Employee
      for “good reason” shall entitle the Employee to the same compensation and
      benefits as if the Employee had been terminated by the Company without cause.
      In
      the event of a termination by the Employee for “good reason,” the provisions of
Section
      3.3
      shall
      not apply and shall be of no force or effect. Upon any resignation by the
      Employee, the Employee shall use reasonable best efforts to assist the Company
      in good faith to effect a smooth transition. If employee voluntarily resigns
      his
      position without “good reason” prior to the termination of this contract the
      compensation terms of this agreement are null and void.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Section
      4.2.
      Termination
      by the Company without Cause.
      At any
      time, the Company may, in its sole and absolute discretion, terminate the
      Employee's employment with the Company (the actual date of termination being
      referred to as the "Termination Date") without cause, by providing written
      notice thereof to the Employee ("Termination Notice") at least ninety days
      (90)
      prior to the Termination Date. In the event of termination of the Employee's
      employment pursuant to this Section, the Company shall continue to pay to the
      Employee the Employee’s then current Annual Salary throughout such ninety-day
      (90) notice period and shall pay the Employee as compensation for loss of office
      (a) twelve months Annual Salary at the Employee’s then current salary in equal
      monthly installments over the twelve month period following the Termination
      Date, provided that such payments shall cease if the Employee becomes employed
      by a company which is in the Business during such twelve month period, and
      (b)
      all vacation accrued as of the Termination Date calculated in accordance with
      Section
      1.2.4.
      Upon
      receipt by the Employee of a Termination Notice pursuant to this Section
      4.2,
      (a) the
      Employee shall assist the Company in good faith to effect a smooth transition,
      and (b) the Company may request the Employee to vacate the premises owned by
      the
      Company and used in connection with the Business within a reasonable time,
      provided that the obligation of the Company to make payments to the Employee
      pursuant to this Section
      4.2
      and the
      other provisions of this Agreement shall not be affected, provided further,
      that
      in the event of a termination by the Company without cause pursuant to this
      Section
      4.2,
      the
      provisions of Section
      3.3
      shall
      not apply and shall be of no further force or effect.

     

    Section
      4.3.
      Termination
      by the Company With Cause.
      This
      Agreement shall be deemed to be terminated and the employment relationship
      between the Employee and the Company shall be deemed severed upon written notice
      to the Employee by the Company after the occurrence of any of the
      following:

     

    
      	
              a)

            	
              The
                final, non-appealable imposition of any restrictions or limitations
                by any
                governmental authority having jurisdiction over the Employee to such
                an
                extent that he cannot render the services for which he was
                employed.

            
	
               

            	
               

            
	
              b)

            	
              The
                Employee (i) willfully and continually fails or refuses (without
                proper
                cause) to substantially perform the duties of his employment and
                to adhere
                in all material respects to the provisions of this Agreement and
                the
                written policies of the Company, which failure shall not be remedied
                within thirty (30) days after written notice from the Company to
                the
                Employee, or (ii) conducts himself in a fraudulent manner, or (iii)
                conducts himself in an unprofessional or unethical manner which in
                the
                reasonable judgment of the Board of Directors of the Company is
                detrimental to the Company.

            
	
               

            	
               

            
	
              c)

            	
              The
                Employee willfully and continually fails or refuses to adhere to
                any
                written agreements to which the Employee and the Company or any of
                its
                affiliates are parties, which failure shall not be remedied within
                thirty
                (30) days after written notice from the Company to the
                Employee.

            
	
               

            	
               

            
	
              d)

            	
              In
                the event of death of the Employee during employment. In such event
                the
                Company shall pay to the estate of the Employee the compensation
                earned by
                the Employee prior to his death but not yet paid to him by the Company.
                

            

    

     

    ARTICLE
      5

     

    Change
      in Control

    

    The
      Board
      of Directors of the Company (“the Board”) has determined that it is in the best
      interests of the Company and its shareholders to assure that the Company will
      have the continued dedication of the Executive, notwithstanding the possibility
      or occurrence of a Change in Control of the Company. The Board believes it
      is
      imperative to diminish the inevitable distraction of the Employee by virtue
      of
      the personal uncertainties and risks created by a pending or threatened Change
      in Control and to encourage the Executive’s full attention and dedication to the
      Company currently and in the event of any pending, threatened or actual Change
      in Control, and to provide the Employee with compensation and benefits
      arrangements upon a Change in Control which are consistent with the Employee’s
      significant leadership position and which are competitive. (See Addendum A
      for
      Definition of Change in Control)

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Section
      5.1 Involuntary Termination/Change in Control. In
      the
      case of involuntary termination of the Employee, resulting from a Change in
      Control of the Company, and due to one or more of the following conditions
      being
      met up to one year following such Change in Control:

     

    
      	 	
              a.

            	
              Elimination
                or diminution of the Employee’s position, authority, duties and
                responsibilities relative to the most significant of those held,
                exercised and assigned at any time during the six month period immediately
                preceding a Change in Control;

            

    

     

    
      	 	
              b.

            	
              Change
                in location requiring the Employee’s services to be performed at a
                location other than the location where the Employee was employed
                immediately preceding a Change in Control, other than any office
                which is
                the headquarters of the Company and is less than 35 miles from such
                location.

            

    

     

    The
      Employee will receive written notice of involuntary termination and will be
      paid
      compensation in terminal pay and participation in benefits, savings and
      retirement plans as summarized below.

    

    Section
      5.2 Voluntary Termination/Change in Control. In
      the
      event of change in control, which does not result in involuntary termination
      of
      the Employee or diminution of the Employee’s position, authority, duties and
      responsibilities, the Employee may elect to voluntarily terminate within one
      year of the Change in Control and may elect the Change in Control provisions
      summarized below.

    

    Section
      5.3 Terminal Pay.
      The
      Employee will receive terminal pay, to be paid in equal installments in
      semi-monthly installments, at least equal to two(2) years annual base salary
      payable to the Employee by the Company in respect of the twelve-month period
      immediately preceding termination.

    

    Section
      5.4 Special Bonus.
      In
      addition to the Terminal Pay and Annual Bonus, the Employee will be eligible,
      based on performance, for any special bonus program which may be instituted
      by
      the Company in recognition of particular assignments, duties or responsibilities
      required during the crucial transition period leading up to, or following,
      the
      Change in Control.

    

    Section
      5.5 Benefits, Savings and Retirement Plans.
      During
      the period of terminal payments, the Employee will remain in employee status
      for
      benefits purposes only and will be entitled to participate in all benefits,
      savings and retirement plans, practices, policies and programs of the Company
      applicable generally to other peer executives of the Company, with the
      expectation that the Employee continues to make all applicable employee
      contributions to said program(s). 

     

    ARTICLE
      6

    

    Guarantee

     

    BASi
      hereby unconditionally and irrevocably guarantees to the Employee the due
      performance by the Company of all its obligations under or in respect of the
      terms of this Agreement and shall as primary obligor and not as surety on demand
      pay to the Employee all sums due to be paid by the Company to the Employee.
      This
      guarantee shall be a continuing guarantee and shall inure to the benefit of
      the
      Employee, his heirs, successors and assigns.

     

    ARTICLE
      7

     

    Miscellaneous

     

    Section
      7.1.
      Relationship
      between the Parties.
      The
      relationship between the Company and the Employee shall be that of an employer
      and an employee, and nothing contained herein shall be construed or deemed
      to
      give the Employee any interest in any of the assets of the Company.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Section
      7.2.
      Notices.
      Any
      notice required or permitted to be given under this Agreement shall be in
      writing and delivered personally or sent by certified mail, addressed to the
      party entitled to receive said notice, at the following addresses:

     

    
      	
               

            	
              If
                to Company:

            	
              Bioanalytical
                Systems Evansville

            
	
               

            	
               

            	
              2701
                Kent Avenue

            
	
               

            	
               

            	
              West
                Lafayette, IN 47906

            
	
               

            	
               

            	
               

            
	
               

            	
              If
                to Employee:

            	
              Michael
                R. Cox

            
	
               

            	
               

            	
              5521
                Turkey Foot Road

            
	
               

            	
               

            	
              Zionsville,
                IN 46077

            

    

                                   

    or
      at
      such other address as may be specified from time to time in notices given in
      accordance with the provisions of this Section
      7.2.

     

    Section
      7.3 Enforceability.
      Both
      the Company and the Employee stipulate and agree that if any portion, paragraph
      sentence, term or provision of this Agreement shall to any extent be declared
      illegal, invalid or unenforceable by a duly authorized court of competent
      jurisdiction, then, (a) the remainder of this Agreement or the application
      of
      such portion, paragraph, sentence, term or provision in circumstances other
      than
      those as to which it is so declared illegal, invalid or unenforceable, shall
      not
      be affected thereby, (b) this Agreement shall be construed in all respects
      as if
      the illegal, invalid or unenforceable matter had been omitted and each portion
      and provision of this Agreement shall be valid and enforceable to the fullest
      extent permitted by law and (c) the illegal, invalid or unenforceable portion,
      paragraph, sentence, term or provision shall be replaced by a legal, valid
      and
      enforceable provision which most closely reflects the intention of the parties
      hereto as reflected herein.

     

    Section
      7.4.
      Nonwaiver.
      The
      failure of either party hereto to insist in any one or more instances upon
      performance of any of the provisions of this Agreement or to pursue its or
      his
      rights hereunder shall not be construed as a waiver of any such provisions
      or as
      the relinquishment of any such rights.

     

    Section
      7.5.
      Succession.
      This
      Agreement shall inure to the benefit of and be binding upon the parties hereto
      and upon their heirs, personal representatives, and successor entities. This
      Agreement may not be assigned by either party without prior written agreement
      of
      both parties.

     

    Section
      7.6.
      Governing Law.
      The
      laws of the United States and the State of Indiana shall govern the construction
      and enforceability of this Agreement.

     

    Section
      7.7.
      Entire
      Agreement.
      This
      Agreement constitutes the entire Agreement between the parties as to the subject
      matter contained herein and all other agreements or understandings are hereby
      superseded and terminated.

     

    Section
      7.8.
      Collective
      Agreements.
      There
      are no collective agreements which directly affect the terms and conditions
      of
      the Employee's employment.

     

    Section
      7.9.
      Grievance
      and Disciplinary Procedures.
      If the
      Employee wishes to obtain redress of any grievance relating to his employment
      or
      if he is dissatisfied with any reprimand, suspension or other disciplinary
      steps
      taken by the Company, he shall apply in writing to the Chairman of the board
      of
      directors of the Company, setting out the nature and details of any such
      grievance or dissatisfaction.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Section
      7.10.
      Heading.
      The
      headings of the sections are inserted for convenience only and do not effect
      the
      interpretation or construction of the sections.

     

    Section
      7.11. Remedies.
      Employee acknowledges that a remedy at law for any breach or threatened breach
      of the provisions of Sections 3.1 through 3.3 of this Agreement would be
      inadequate and therefore agrees that the Company shall be entitled to injunctive
      relief, both preliminary and permanent, in addition to any other available
      rights and remedies in case of any such breach or threatened breach; provided,
      however, that nothing contained herein shall be construed as prohibiting the
      Company from pursuing any other remedies available for any such breach or
      threatened breach. Employee further acknowledges and agrees that in the event
      of
      a breach by Employee of any provision of Sections 3.1 through 3.3 of this
      agreement, the Company shall be entitled, in addition to all other remedies
      to
      which the Company may be entitled under this Agreement to recover from Employee
      its reasonable costs including attorney's fees if the Company is the prevailing
      party in an action by the Company. This Agreement is entered into by the Company
      for itself and in trust for each of its affiliates with the intention that
      each
      company will be entitled to enforce the terms of this Agreement directly against
      Employee.

     

    IN
      WITNESS WHEREOF, the Company and the Employee have executed, or caused to be
      executed, this Agreement as of the day and year first written
      above.

     

    
      	
              "COMPANY"

            	 	
              "EMPLOYEE"

            	 
	
               

            	 	
               

            	 
	
               

            	 	
               

            	 
	
              /s/  Richard
                M. Shepperd

            	 	
              /s/  Michael
                R. Cox

            	 
	 	 	 	 
	 	 	 	 
	
              Richard
                M. Shepperd

            	 	 	 
	
              President
                & CEO

            	 	
              Michael
                R. Cox

            	 
	
              Bioanalytical
                Systems, Inc.

            	 	
               

            	 

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    ADDENDUM
      A

    Michael
      R. Cox Employment Agreement

    

    A
“Change
      in Control” shall mean the occurrence of any of the following
      events:

    

    
      	 	
              1.

            	
              Approval
                by stockholders of the Company of (a) any consolidation or merger of the
                Company in which the Company is not the continuing or surviving
                corporation or pursuant to which shares of stock of the company would
                be
                converted into cash, securities or other property, other than a
                consolidation or merger of the company in which holders of its common
                stock immediately prior to the consolidation or merger have substantially
                the same proportionate ownership of common stock of the surviving
                corporation immediately after the consolidation or merger as immediately
                before, or (b) a sale, lease, exchange or other transfer (in one
                transaction or a series of related transactions) of all or substantially
                all the assets of the company.

            

    

    

    
      	 	
              2.

            	
              A
                change in the majority of members of the board within a 24-month
                period
                unless the election or nomination for election by the Company stockholders
                of each new director was approved at a vote of two thirds of the
                directors
                then still in office who were in office at the beginning of the 24-month
                period.

            

    

    

    
      	 	
              3.

            	
              Either
                (A) receipt by the Company of a report on schedule 13D, or an amendment
                to
                such a report, filed with the Securities and Exchange Commission
                (“SEC”)
                pursuant to Section 13(d) of the Securities Exchange Act of 1934
                (the
                “1934 Act”) disclosing that any person, group, corporation or other entity
                is the beneficial owner, directly or indirectly, of 20 per cent or
                more of
                the outstanding stock of the company or (B) actual knowledge by the
                company of facts, on the basis of which any person is required to
                file
                such a report on schedule 13D, or an amendment to such a report,
                with the
                SEC (or would be required to file such a report or amendment upon
                the
                lapse of the applicable period of time Specified in Section 13(d)
                of the
                1934 Act) disclosing that such a person is the beneficial owner,
                directly
                or indirectly, of 20 per cent or more of the outstanding stock of
                the
                company.

            

    

    

    
      	 	
              4.

            	
              Purchase
                by any person (as defined in section 13(d) of the 1934 Act), corporation
                or other entity, other than the company or a wholly-owned subsidiary
                of
                the company, of shares pursuant to a tender or exchange offer, to
                acquire
                any stock of the Company (or securities convertible into stock) for
                cash,
                securities or any other consideration provided that, after consummation
                of
                the offer, such person, group, corporation or other entity is the
                beneficial owner (as defined in rule 13d-3 under the 1934 Act), directly
                or indirectly, of 20 per cent or more of the outstanding stock of
                the
                Company (calculated as provided in paragraph (d) of Rule 13d-3 under
                the
                1934 Act in the case of rights to acquire
                stock.

            

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    ADDENDUM
      A, Page 2

     

    5.
      The
      Company combines with another company and is the surviving corporation but,
      immediately after the combination, the shareholders of the Company immediately
      prior to the combination do not hold, directly or indirectly, more than 50
      per
      cent of the Voting Stock of the combined company (there being excluded from
      the
      number of shares held by such shareholders, but not from the Voting Stock of
      the
      combined company, any shares received by affiliates (as defined in the rules
      of
      the Securities and Exchange Commission) of such other company in exchange for
      stock of such other company).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]